Qnovia
Richmond, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MD
Mario DanekExecutive Officer, Director
BQ
Brian QuigleyExecutive Officer, Director
SF
Sean FaheyDirector
BR
Brian RianoDirector
GS
Gregg SmithDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$14.2MraisedNov 2024 · 7 investors · PharmaceuticalsRule 506(b)
▶$14.2MraisedNov 2024 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mario DanekExecutive Officer, Director
- Sean FaheyDirector
- Brian QuigleyExecutive Officer, Director
- Brian RianoDirector
- Gregg SmithDirector
- Offering amount
- $16M
- Amount sold
- $14.2M
- Proceeds to insiders
- $1.6M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedJun 2023 · 3 investors · BiotechnologyRule 506(b)
▶$2.9MraisedJun 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian RianoDirector
- Mario DanekExecutive Officer, Director
- Brian QuigleyExecutive Officer, Director
- Gregg SmithDirector
- Sean FaheyDirector
- Offering amount
- $5M
- Amount sold
- $2.9M
- Proceeds to insiders
- $500K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.2MraisedAug 2022 · BiotechnologyRule 506(b)
▶$24.2MraisedAug 2022 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian QuigleyDirector
- Mario DanekDirector
- Gregg SmithDirector
- Sean FaheyDirector
- Offering amount
- $30M
- Amount sold
- $24.2M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.